These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28618980)

  • 1. Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
    Wolff MJ; Cortes CP; Mejìa FA; Padgett D; Belaunzarán-Zamudio P; Grinsztejn B; Giganti MJ; McGowan CC; Rebeiro PF;
    Int J STD AIDS; 2018 Jan; 29(1):4-12. PubMed ID: 28618980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression.
    Rebeiro PF; Cesar C; Shepherd BE; De Boni RB; Cortés CP; Rodriguez F; Belaunzarán-Zamudio P; Pape JW; Padgett D; Hoces D; McGowan CC; Cahn P
    J Int AIDS Soc; 2016; 19(1):20636. PubMed ID: 27065108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
    Cesar C; Jenkins CA; Shepherd BE; Padgett D; Mejía F; Ribeiro SR; Cortes CP; Pape JW; Madero JS; Fink V; Sued O; McGowan C; Cahn P;
    Lancet HIV; 2015 Nov; 2(11):e492-500. PubMed ID: 26520929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study.
    Angriman F; Belloso WH; Sierra-Madero J; Sánchez J; Moreira RI; Kovalevski LO; Orellana LC; Cardoso SW; Crabtree-Ramirez B; La Rosa A; Losso MH
    Int J STD AIDS; 2016 Feb; 27(2):118-26. PubMed ID: 25740759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.
    Smiley CL; Rebeiro PF; Cesar C; Belaunzaran-Zamudio PF; Crabtree-Ramirez B; Padgett D; Gotuzzo E; Cortes CP; Pape J; Veloso VG; McGowan CC; Castilho JL;
    Lancet HIV; 2021 May; 8(5):e266-e273. PubMed ID: 33891877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
    Lesko CR; Tong W; Moore RD; Lau B
    AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?
    Saunders P; Goodman AL; Smith CJ; Marshall N; O'Connor JL; Lampe FC; Johnson MA
    HIV Med; 2016 Jan; 17(1):18-27. PubMed ID: 26140659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort.
    Tanner Z; Lachowsky N; Ding E; Samji H; Hull M; Cescon A; Patterson S; Chia J; Leslie A; Raboud J; Loutfy M; Cooper C; Klein M; Machouf N; Tsoukas C; Montaner J; Hogg RS;
    BMC Infect Dis; 2016 Oct; 16(1):590. PubMed ID: 27769246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virologic suppression among HIV-infected US Air Force members in a highly-structured programme with free access to care.
    Matthews PE; Le T; Delmar J; Okulicz JF
    Int J STD AIDS; 2015 Nov; 26(13):951-9. PubMed ID: 25505041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.
    Jiamsakul A; Kariminia A; Althoff KN; Cesar C; Cortes CP; Davies MA; Do VC; Eley B; Gill J; Kumarasamy N; Machado DM; Moore R; Prozesky H; Zaniewski E; Law M
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):319-329. PubMed ID: 28708808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
    Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
    J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is substance use associated with HIV cascade outcomes in Latin America?
    De Boni RB; Peratikos MB; Shepherd BE; Grinsztejn B; Cortés C; Padgett D; Gotuzzo E; Belaunzarán-Zamudio PF; Rebeiro PF; Duda SN; McGowan CC;
    PLoS One; 2018; 13(3):e0194228. PubMed ID: 29543857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIV Care Continuum: Changes over Time in Retention in Care and Viral Suppression.
    Yehia BR; Stephens-Shields AJ; Fleishman JA; Berry SA; Agwu AL; Metlay JP; Moore RD; Christopher Mathews W; Nijhawan A; Rutstein R; Gaur AH; Gebo KA;
    PLoS One; 2015; 10(6):e0129376. PubMed ID: 26086089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time Spent with HIV Viral Load > 1500 Copies/mL Among Persons Engaged in Continuity HIV Care in an Urban Clinic in the United States, 2010-2015.
    Lesko CR; Lau B; Chander G; Moore RD
    AIDS Behav; 2018 Nov; 22(11):3443-3450. PubMed ID: 29541913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in Rwanda.
    Riedel DJ; Stafford KA; Memiah P; Coker M; Baribwira C; Sebeza J; Karorero E; Nsanzimana S; Morales F; Redfield RR
    Int J STD AIDS; 2018 Aug; 29(9):861-872. PubMed ID: 29621951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.